At the end of their cycle, hematocrit amounts experienced amplified by three%-stage as opposed with baseline. The rise wasn't associated with for a longer time use or higher AAS dose. A cause for this could possibly be that, outside of a specific standard of androgenic activity, no further more enhance of hematocrit occurs: a ‘ceiling influence�